Creavo Medical Technologies is an innovative British company developing diagnostics technology for acute medical settings.

The company was set up to commercialise technology that was developed at the University of Leeds by Professor Ben Varcoe that will revolutionise front-line patient triage for chest pain; speeding decision-making, offering better patient management and crucially saving time and NHS resources.


Further Information

Interview: Prof Mark Kearney

Professor Mark Kearney talks about current guidelines and their implications.

Interview: Dr Francis Morris

Dr Francis Morris talks about identifying patients with heart attacks.

Creavo Medical Technologies IET award wins

At the 2017 IET Innovation Awards, we won the Emerging Technology Design and Healthcare Technologies awards.

Latest News


Creavo attending Royal College of Emergency Medicine event

Creavo Medical Technologies will be exhibiting at the Royal College of Emergency Medicine Spring CPD Conference in Cardiff from 17 – 19 April 2018. If you’re an emergency physician and would like to find out more about how our device can help you accurately and rapidly rule out ischaemic heart disease in patients presenting with … Continue reading Creavo attending Royal College of Emergency Medicine event


Our cardiac imaging device triumphs at IET Innovation Awards

Creavo Medical Technologies has won two awards at the Institution of Engineering and Technology (IET) Innovation Awards for its cutting-edge cardiac imaging device which could help physicians accurately rule-out ischaemic heart conditions in a matter of minutes. The awards celebrate the very best in new innovations in science, engineering and technology, showcasing entries from around … Continue reading Our cardiac imaging device triumphs at IET Innovation Awards


Creavo Medical Technologies secures U.S. FDA 510(k)

Technology has the potential to revolutionise emergency department triage of chest pain patients. Developer of innovative medical diagnostic technology, Creavo Medical Technologies, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The move opens the U.S. market for its portable scanning device, Vitalscan, and demonstrates an increasing industry focus on the global … Continue reading Creavo Medical Technologies secures U.S. FDA 510(k)


Read the ‘Full Hearts’ article in CEO Magazine featuring Creavo’s CEO, Steve Parker

Our CEO, Steve Parker, was interviewed for a feature in this October’s CEO Magazine, where he discussed our device and its potentially game-changing technology. With Steve’s vast experience in the medtech industry, it makes for an interesting read. Take a look at the online version here.


European Society for Emergency Medicine Congress 2017

Creavo will be attending the European Society for Emergency Medicine in Athens from 24 – 27 September. Come and visit us on stand H11, we would love to hear from you!


Read our CSO’s latest blog in the Huffpost

Our Chief Scientific Officer, Professor Ben Varcoe, has written a blog on HuffPost about how our device uses magnetocardiography to help rule out cardiac conditions in chest pain patients, helping to combat the volume of them put through the lengthy A&E triage process. Click here to find out more.